Stein, E.M.
Dash, A.
Bucovsky, M.
Agarwal, S.
Fu, J.
Lentzsch, S.
Shane, E.
Funding for this research was provided by:
Foundation for the National Institutes of Health (K23 DK084337, U01 AR055968)
Linden Trust
Article History
Received: 22 June 2018
Revised: 12 November 2018
Accepted: 18 November 2018
First Online: 28 November 2018
Compliance with ethical standards
:
: Emily Stein, Alexander Dash, Sanchita Agarwal, Mariana Bucovsky, Jing Fu, Elizabeth Lentzsch, and Elizabeth Shane declare that they have no conflict of interest. Dr. Lentzsch is chief scientific advisor and shareholder of Caelum Biosciences and advisor for Janssen, Bayer, and Karyopharm.